Citations (19)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Yuting Kuang, Binya Hu, Min Huang, Sijun Zhao, Xionghui Wu, Mengping Zhang & Zhong Xie. (2022) Phosphatidylethanolamine-binding protein 1 (PEBP1) mediates the regulatory role of microRNAs (miRNAs)-205-5p in degranulation and histamine release. Bioengineered 13:5, pages 13341-13351.
Read now
Read now
Hakan Parlakpinar & Mehmet Gunata. (2021) Transplantation and immunosuppression: a review of novel transplant-related immunosuppressant drugs. Immunopharmacology and Immunotoxicology 43:6, pages 651-665.
Read now
Read now
Articles from other publishers (17)
Parniyan Sadeghi, Parmida Sadat Pezeshki & Nima Rezaei. (2023) Coronavirus disease 2019 (COVID-19) in pediatric patients with autoimmune disorders. European Journal of Pediatrics 182:7, pages 2967-2988.
Crossref
Crossref
Daniele Giovanni Ghiglioni, Laura Cozzi, Riccardo Castagnoli, Gaia Bruschi, Laura Maffeis, Paola Giovanna Marchisio, Gian Luigi Marseglia & Amelia Licari. (2023) Omalizumab may protect allergic patients against COVID-19: A systematic review. World Allergy Organization Journal 16:2, pages 100741.
Crossref
Crossref
Huijun Chen, Xiaoli Zhang, Ge Lin, Fei Gong & Berthold Hocher. (2023) Safety of COVID-19 vaccination in women undergoing IVF/ICSI treatment - Clinical study and systematic review. Frontiers in Immunology 13.
Crossref
Crossref
Tayrine Ordonio Filgueira, Paulo Roberto Cavalcanti Carvalho, Matheus Santos de Sousa Fernandes, Angela Castoldi, Ana Maria Teixeira, Renata Bezerra de Albuquerque, José Luiz de Lima-Filho & Fabrício Oliveira Souto. (2023) The impact of supervised physical exercise on chemokines and cytokines in recovered COVID-19 patients. Frontiers in Immunology 13.
Crossref
Crossref
Hironori Nishitsuji, Satoko Iwahori, Mariko Ohmori, Kunitada Shimotohno & Takayuki Murata. (2022) Ubiquitination of SARS-CoV-2 NSP6 and ORF7a Facilitates NF-κB Activation. mBio 13:4.
Crossref
Crossref
Pooria Fazeli, Mohammadreza Saeidnia, Mehran Erfani & Mehdi Kalani. (2022) An overview of the biological and multifunctional roles of IL-38 in different infectious diseases and COVID-19. Immunologic Research 70:3, pages 316-324.
Crossref
Crossref
Anna Campanati, Federico Diotallevi, Emanuela Martina, Giulia Radi & Annamaria Offidani. (2022) Treatment of Moderate to Severe Psoriasis during the COVID-19 Pandemic: Lessons Learned and Opportunities. Journal of Clinical Medicine 11:9, pages 2422.
Crossref
Crossref
Haider Ghazanfar, Sameer Kandhi, Dongmin Shin, Aruna Muthumanickam, Hitesh Gurjar, Zaheer A Qureshi, Mohammed Shaban, Mohamed Farag, Asim Haider, Pravash Budhathoki, Tanushree Bhatt, Ali Ghazanfar, Abhilasha Jyala & Harish Patel. (2022) Impact of COVID-19 on the Gastrointestinal Tract: A Clinical Review. Cureus.
Crossref
Crossref
Huijuan Li, Yan Li, Chunxiang Luo, Xueyan Liang, Zixuan Liu, Yu Liu & Yunzhi Ling. (2022) New Approach for Targeted Treatment of Mild COVID-19 by Honeysuckle through Network Pharmacology Analysis. Computational and Mathematical Methods in Medicine 2022, pages 1-12.
Crossref
Crossref
Y. Lytvyn, J.R. Georgakopoulos, A. Mufti, A.R. Devani, M.J. Gooderham, V. Jain, P. Lansang, R. Vender, V.H. Prajapati & J. Yeung. (2021) Incidence and prognosis of COVID‐19 in patients with psoriasis on apremilast: a multicentre retrospective cohort study. Journal of the European Academy of Dermatology and Venereology 36:2.
Crossref
Crossref
Eberhard Wieland. (2022) Immunological Biomarkers in Blood to Monitor the Course and Therapeutic Outcomes of COVID-19. Therapeutic Drug Monitoring 44:1, pages 148-165.
Crossref
Crossref
Abdolreza Esmaeilzadeh, Nazila Bahmaie, Elham Nouri, Mohammad Javad Hajkazemi & Maryam Zareh Rafie. (2021) Immunobiological Properties and Clinical Applications of Interleukin-38 for Immune-Mediated Disorders: A Systematic Review Study. International Journal of Molecular Sciences 22:22, pages 12552.
Crossref
Crossref
Jared RobinsonIndrajit BanerjeeAlexandra Leclézio. (2021) Pharmacotherapy of Cytokine Release Syndrome in Severe COVID-19 Patients: A Systematic Review. Global Journal of Medical, Pharmaceutical, and Biomedical Update 16, pages 8.
Crossref
Crossref
Ionuț Jeican, Dan Gheban, Lucian Barbu-Tudoran, Patricia Inișca, Camelia Albu, Maria Ilieș, Silviu Albu, Mihaela Vică, Horea Matei, Septimiu Tripon, Mihaela Lazăr, Maria Aluaș, Costel Siserman, Monica Muntean, Veronica Trombitas, Cristina Iuga, Iulian Opincariu & Lia Junie. (2021) Respiratory Nasal Mucosa in Chronic Rhinosinusitis with Nasal Polyps versus COVID-19: Histopathology, Electron Microscopy Analysis and Assessing of Tissue Interleukin-33. Journal of Clinical Medicine 10:18, pages 4110.
Crossref
Crossref
Benedicto Crespo-Facorro, Miguel Ruiz-Veguilla, Javier Vázquez-Bourgon, Ana C. Sánchez-Hidalgo, Nathalia Garrido-Torres, Jose M. Cisneros, Carlos Prieto & Jesus Sainz. (2021) Aripiprazole as a Candidate Treatment of COVID-19 Identified Through Genomic Analysis. Frontiers in Pharmacology 12.
Crossref
Crossref
Robert Root-Bernstein. (2021) Innate Receptor Activation Patterns Involving TLR and NLR Synergisms in COVID-19, ALI/ARDS and Sepsis Cytokine Storms: A Review and Model Making Novel Predictions and Therapeutic Suggestions. International Journal of Molecular Sciences 22:4, pages 2108.
Crossref
Crossref
Peipei Liu, Zhongzong Pan, Chunyin Gu, Xiaodan Cao, Xiaowu Liu, Jianjian Zhang, Zheng Xiao, Xueping Wang, Haibing Guo, Dianwen Ju & Su-Jun Deng. (2020) An Omalizumab Biobetter Antibody With Improved Stability and Efficacy for the Treatment of Allergic Diseases. Frontiers in Immunology 11.
Crossref
Crossref